TBD-Biodiscovery, a biotechnology company based in Tartu, Estonia’s second largest town, has received an all timelargest investment brought to the Estonian biotech sector. TBD-Biodiscovery’s main activities are production and development of active pharmaceutical ingredients. The company’s premises are in Tartu Biotechnology Park. The new Dutch stakeholder, SEAL Investments B.V acquired 30% of TBD and invests[…]
Hollandi ettevõte investeerib Tartus tegutsevasse ravimiettevõttesse TBD-Biodiscovery 4,5 miljonit eurot, mis on kõigi aegade suurim välisinvesteering Eesti biotehnoloogiaettevõttesse. Tartu Biotehnoloogia Pargis tegutseva ravimite toimeaineid arendava ja müüva ettevõttega TBD-Biodiscovery liitusid Hollandi partnerid firmast SEAL Investment B.V, kes omandasid Eesti ettevõttes 30 protsendilise osaluse ning investeerivad ettevõttesse paari lähima aasta jooksul 4,5 miljonit eurot. TBD-Biodiscovery juhatuse[…]
Chemspec Europe exclusively focuses on the fine, custom and speciality chemicals sector. The international event brings together suppliers and purchasers looking for bespoke products or specific substances to enhance a product/drug or develop new chemical solutions. Dr. Olga Tšubrik (Head of Business Development) will attend Chemspec 26.06-27.06.2019 in Basel.
TBD-Biodiscovery has continuously been supporting local young chemists. Baltic Chemistry Olympiad will be held in Tartu (11.04-13.04.2019). TBD-Biodiscovery will hand over the prize to the best participant in the finals of the experimental work.
March 21, 2019 TBD-Biodiscovery has always supported the education of young chemists. We were happy to introduce our company to young chemistry students and professor Säde Viirlaid from University of Tartu.
March 2019 TBD-team has grown and gained new members. Ms Kristiine Pai joined TBD`sales department as a sales representative and Ms Tiina Tasa as an administrative manager.
March 25-28, 2019 Dr. Olga Tšubrik (Head of Business Development), attended the Bio-Spring 2019 in Vienna.
TBD-Biodiscovery in cooperation with Tartu Biotechnology Park and Association of the Latvian Chemical-Pharmaceutical Industry (LAKIFA) and PharmIdea had a collaboration and matchmaking event. The current situation and collaboration opportunities in the sector in both countries were discussed.
October 9-11, 2018 Dr. Olga Tšubrik (Head of Business Development), Dr. Andrus Tasa (Member of the Management Board) and Ms. Triin Käbin (Client Manager) will attend the CPhI Worldwide in Madrid. Please visit us in booth 10J122. To schedule the meeting please contact us at email@example.com.
Our Chairman of the Management Board Dr. Andrus Tasa has joined the Business Delegation who accompanies the President of the Republic of Estonia H.E. Mrs. Kersti Kaljulaid in official visit to Ukraine on May 22nd to May 23rd, 2018. The delegation of 28 members will meet the local companies and will take part of Estonian-Ukrainian[…]